Last updated on April 2018

A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)


Brief description of study

This study evaluates the efficacy and safety of the experimental drug, BLS-ILB-E710c, in patients with Cervical Intraepithelial Neoplasia 2/3 (CIN2/3). 2/3 of participants will receive the experimental drug, while 1/3 of participants will receive placebo.

Detailed Study Description

Primary Outcome Measure:

Complete histopathological regression from baseline [Time Frame: Baseline through Week 16]

Secondary Outcome Measures:

  • Change from baseline of CIN classification [Time Frame: Baseline through Week 16]
  • Change from baseline of RCI [Time Frame: Baseline through Week 16 and Week 32]
  • Change from baseline of cytopathological classification based on bethesda system [Time Frame: Baseline through Week 16 and Week 32]
  • Change from baseline as compared to placebo in the expression rate of P16/Ki-67 [Time Frame: Baseline through Week 16]
  • Change from baseline as compared to placebo of the number of CD8 positive cells in the cervical tissue [Time Frame: Baseline through Week 16]
  • Change from baseline as compared to placebo in HPV 16 clearance rate
  • Change of RCI based on the histopathological regression at Week 16 [Time Frame: Week 16 through Week 32]

Clinical Study Identifier: NCT03274206

Contact Investigators or Research Sites near you

Start Over

Nak-Woo Lee, MD, PhD

Korea University Ansan Hospital
Ansan, Korea, Republic of
  Connect »

Sung Jong Lee, MD, PhD

Catholic University of Korea, St. Vincent's Hospital
Suwon, Korea, Republic of
  Connect »

Jin Hui Kim, MD, PhD

Catholic University of Korea, Uijeongbu St. Mary's Hospital
Uijeongbu, Korea, Republic of
  Connect »

Chi-Heum Cho, MD, PhD

The Dongsan Medical Center of Keimyung Hospital
Daegu, Korea, Republic of
  Connect »

Jin Woo Shin, MD, PhD

Gachon University Gil Medical Center
Incheon, Korea, Republic of
  Connect »

Young Tae Kim, MD, PhD

Yonsei Unversity Health System
Seoul, Korea, Republic of
  Connect »

Soo Young Hur, MD, Ph.D

Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, Korea, Republic of
  Connect »

Sung Taek Park, MD, PhD

Hallym University Medical Center
Seoul, Korea, Republic of
  Connect »

Tae Jin Kim, MD, PhD

Kwandong University College of Medicine Cheil Hospital
Seoul, Korea, Republic of
  Connect »

Seok Ju Seong, MD, PhD

CHA Gangnam Hospital
Seoul, Korea, Republic of
  Connect »

Jae-Kwan Lee, MD, PhD

Korea University Guro Hospital
Seoul, Korea, Republic of
  Connect »

Seung Hun Song, MD, PhD

CHA Bundang Medical Center, CHA University
Seongnam si, Korea, Republic of
  Connect »

Jae-Weon Kim, MD, PhD

Seoul National University Hospital
Seoul, Korea, Republic of
  Connect »

Yong-Man Kim, MD, Ph.D

University of Ulsan College of Medicine, Asan Medical Center
Seoul, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.